NEW YORK (GenomeWeb News) – Qiagen today said it has joined a global initiative to develop affordable and portable molecular diagnostics for resource-poor regions of the world.

The Point-of-Care Diagnostics Initiative is led by the Bill and Melinda Gates Foundation and Grand Challenges Canada and targets the development of new molecular diagnostic platforms to improve healthcare in the poorest regions of the world. Qiagen joins more than 20 other non-profits, academic, and corporate organizations in the initiative.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.